Previous Article | Next Article ![]()
Infection and Immunity, April 1999, p. 1943-1946, Vol. 67, No. 4
Otitis Media Research
Center,1 Departments of
Otolaryngology2 and
Pediatrics,
Received 22 September 1998/Returned for modification 16 November
1998/Accepted 18 January 1999
Streptococcus pneumoniae is the most frequent microbe
causing middle ear infection. The pathophysiology of pneumococcal
otitis media has been characterized by measurement of local
inflammatory mediators such as inflammatory cells, lysozyme, oxidative
metabolic products, and inflammatory cytokines. The role of cytokines
in bacterial infection has been elucidated with animal models, and interleukin (IL)-1 The natural history of local
inflammatory responses in middle ear infection has been investigated
with animal otitis media models infected with clinically
important bacterial species. Streptococcus pneumoniae is the
most prevalent middle ear bacterial pathogen, cultured from
approximately 40% of middle ear fluid (MEF) samples from children with
acute otitis media (AOM) (2, 9) and 7% of MEF samples from
children with chronic otitis media with effusion (OME) (2).
We have studied the pathophysiology of pneumococcal AOM using the
chinchilla otitis media model (18, 19, 23, 28, 29) and
in the guinea pig model otitis media model induced by
Haemophilus influenzae (17, 24, 25) and
Moraxella catarrhalis (27). Inflammatory cells,
lysozyme, and oxidative metabolic products have been recognized as
being important contributors to acute middle ear inflammation.
The presence of cytokines in MEF samples obtained from children with
OME has been reported (5, 11, 16, 21, 22, 30, 32-34), and
similar observations have been reported for otitis media animal
models (1, 7, 14, 15). We recently observed that
interleukin (IL)-1 A total of 28 healthy adult chinchillas weighing 400 to 600 g with normal middle ears, ascertained by otoscopy and tympanometry, were used. Eustachian tube obstruction was performed 24 h before inoculation to prevent the inoculum from flowing out of the Eustachian tube (3). All procedures were performed on ketamine
hydrochloride-anesthetized animals. All procedures were performed in
accordance with the Public Health Service Policy on Human Care and Use
of Laboratory Animals, the National Institutes of Health Guide for Care
and Use of Laboratory Animals, and the Animal Welfare Act (Public Law
89-144 as amended). The animal use protocol was approved by the
Institutional Animal Care and Use Committee of the University of
Minnesota. A type 3 S. pneumoniae strain (kindly
provided by James C. Paton, Department of Microbiology, Women's and
Children's Hospital, North Adelaide, Australia) was used. The
pneumococcal strain was prepared for inoculation as previously
described (28). One milliliter of the prepared 4-h log-phase
pneumococcal inoculum containing approximately 40 CFU was placed
directly into both middle ear hypotympanic bullae of the chinchillas
(23).
MEF (200 µl) was sampled 1 (6 ears), 2 (16 ears), 4 (16 ears), 6 (16 ears), 12 (36 ears), 24 (36 ears), 48 (36 ears), and 72 h (32 ears) after pneumococcal inoculation. The same ear was tapped on two to
four successive occasions. Quantitative MEF cultures were performed on
sheep blood agar for the MEF sampled between 12 and 72 h; the
quantitation threshold was 50 CFU/ml. Inflammatory cells in MEF samples
were enumerated with a hemocytometer, and differential cell enumeration
was performed with Wright's staining (Diff Quick; American Scientific
Products, McGaw Park, Ill.).
All the MEF samples were centrifuged at 500 × g and
frozen at Bacterial concentration (CFU/ml), inflammatory cell numbers
(cells/mm3), and cytokine concentrations (pg/ml) in MEF
were determined. The values were log transformed, and correlations
between inflammatory cell numbers and individual cytokine
concentrations and between the individual cytokines were analyzed by
Pearson's product moment method.
All MEF samples were culture positive for type 3 pneumococci. The
MEF concentration of the log-phase inoculum did not change during the
first 4 h after middle ear inoculation, but the concentration increased exponentially between 6 and 72 h to a geometric mean (GM) of 7.634 log10 CFU/ml at 72 h (Fig.
1). Blood cultures were not obtained in
this study, although prior experience with this serotype in the
chinchilla model (28) has shown the virtual absence of
bacteremia during the first 72 h after middle ear inoculation.
Inflammatory cell concentration in MEF remained constant (GM, 31 to 38 cells/mm3) between 1 and 4 h after inoculation,
followed by an increase to 7,099 cells/mm3 at 72 h,
paralleling the exponential increase in pneumococci (Fig. 1).
Neutrophils predominated (GM, 59 to 75%) among inflammatory cells in
MEF, followed by macrophages (22 to 38%) and lymphocytes (2 to 3%)
between 12 and 72 h. The percentage of neutrophils increased over
the period from 12 (GM, 59%) to 72 h (GM, 75%), while that of
macrophages decreased (GM, 38 to 22%, respectively).
IL-1
0019-9567/99/$04.00+0
Copyright © 1999, American Society for Microbiology. All rights reserved.
Middle Ear Fluid Cytokine and Inflammatory Cell
Kinetics in the Chinchilla Otitis Media Model

![]()
ABSTRACT
Top
Abstract
Introduction
Materials and Methods
Results
Discussion
References
, IL-6, and IL-8 and tumor necrosis
factor alpha (TNF-
) are recognized as being important local
mediators in acute inflammation. We characterized middle ear
inflammatory responses in the chinchilla otitis media model after
injecting a very small number of viable pneumococci into the middle
ear, similar to the natural course of infection. Middle ear fluid (MEF) concentrations of IL-1
, IL-6, IL-8, and TNF-
were measured by using anti-human cytokine enzyme-linked immunosorbent assay
reagents. IL-1
showed the earliest peak, at 6 h after
inoculation, whereas IL-6, IL-8, and TNF-
concentrations were increasing 72 h after pneumococcal
inoculation. IL-6, IL-8, and TNF-
but not IL-1
concentrations
correlated significantly with total inflammatory cell numbers in MEF,
and all four cytokines correlated significantly with MEF
neutrophil concentration. Several intercytokine correlations were
significant. Cytokines, therefore, participate in the early middle ear
inflammatory response to S. pneumoniae.
![]()
INTRODUCTION
Top
Abstract
Introduction
Materials and Methods
Results
Discussion
References
, IL-6, and IL-8 and tumor necrosis factor alpha
(TNF-
) were present in MEF during type 3 S. pneumoniae-induced experimental otitis media in the chinchilla
model; commercially available human enzyme-linked immunosorbent
assay (ELISA) reagents were used (28). We, therefore, sought
to investigate the natural course of cytokines and their interaction
with inflammatory cells during the early stage of middle ear
inflammation in the chinchilla pneumococcal otitis media model.
![]()
MATERIALS AND METHODS
Top
Abstract
Introduction
Materials and Methods
Results
Discussion
References
70°C for batched cytokine assays. Concentrations of
IL-1
, IL-6, and TNF-
in MEF were measured with high-sensitivity
human IL-1
, IL-6, IL-8, and TNF-
ELISA kits (Quantikine; R & D
Systems, Minneapolis, MN). MEF with undetectable cytokine was assigned a value of one-half of the detection threshold of the respective ELISA kits.
![]()
RESULTS
Top
Abstract
Introduction
Materials and Methods
Results
Discussion
References

View larger version (16K):
[in a new window]
FIG. 1.
Log10 mean pneumococcal CFU per milliliter
(solid line, left axis) and log10 mean number of total
inflammatory cells per millimeter3 (broken line, right
axis) in MEF after pneumococcal inoculation. Error bars indicate
standard errors.
was detectable in 50 to 100% of MEF samples between 1 and
6 h and in 16 to 47% of samples between 12 and 72 h (Table 1). The concentration peaked at 6 h
(GM, 17.96 pg/ml) and then declined and appeared to have a secondary
increase at 72 h (Fig. 2). TNF-
was detected in fewer than 15% of samples between 1 and 48 h and
in 40% of samples at 72 h, when the GM concentration was 6.51 pg/ml. IL-6 was detected in 31 to 50% of samples between 2 and 24 h and in 88 to 97% of samples between 48 and 72 h, when the GM
concentration reached 8.29 pg/ml. IL-8 was detected in no samples
before 12 h and was detected in 25 to 38% of samples between 12 and 72 h, when the GM concentration reached 622.57 pg/ml. The
later increases of IL-6, IL-8, and TNF-
were all temporally associated with the increase of inflammatory cells, particularly neutrophils.
TABLE 1.
Cytokine concentration (pg/ml) in MEF

View larger version (16K):
[in a new window]
FIG. 2.
GM concentration of cytokines in MEF after pneumococcal
inoculation. IL-1
, broken line; IL-6, broken-dotted line; IL-8,
dotted line; TNF-
, solid line.
Total inflammatory cell concentration in MEF correlated significantly
with IL-6 (r = 0.580, P < 0.001), IL-8
(r = 0.256, P = 0.009), and TNF-
(r = 0.486, P < 0.001) but not with IL-1
(r = 0.022, P = 0.807) concentrations. Neutrophil concentration correlated significantly with IL-1
(r = 0.327, P = 0.001), IL-6 (r = 0.587, P < 0.001), IL-8
(r = 0.259, P = 0.008), and TNF-
(r = 0.565, P < 0.001) concentrations. Macrophage concentration correlated significantly with IL-1
(r = 0.284, P = 0.003), IL-6 (r = 0.545, P < 0.001), IL-8
(r = 0.256, P = 0.009), and TNF-
(r = 0.518, P < 0.001) concentrations. Lymphocytes correlated significantly with IL-1
(r = 0.297, P = 0.002),
IL-6 (r = 0.329, P = 0.001), TNF-
(r = 0.486, P < 0.001) but not with IL-8 (r = 0.163, P = 0.098).
Correlations between cytokines were significant for the following
pairs: IL-1
and TNF-
(r = 0.254, P < 0.001), IL-6 and IL-8 (r = 0.307, P < 0.001), IL-6 and TNF-
(r = 0.522, P < 0.001), and IL-8 and TNF-
(r = 0.272, P < 0.001). Correlations between the following cytokines were not
significant: IL-1
and IL-6 (r = 0.122, P = 0.116) and IL-1
and IL-8 (r = 0.076, P = 0.321).
The effect of serial ear paracentesis on cell and cytokine
concentrations was examined. At 12 h, inflammatory cell
concentrations were lower in 11 ears aspirated twice than in 26 ears
aspirated once (P < 0.001). At 24 h, cell
concentrations were lower in 8 ears tapped thrice than in 26 ears
tapped twice (P = 0.045). However, cytokine
concentrations had the opposite trend. At 12 h, IL-1
concentrations were higher in 9 ears tapped twice than in 26 ears tapped once (P = 0.001). At 24 h, IL-1
concentrations were not significantly different in 6 ears tapped thrice
than in 26 ears tapped twice (P = 0.406).
Serum samples were not obtained concurrently with MEF samples for use in this study for cytokine analysis. However, none of the four cytokines were detected in serum from uninfected, healthy chinchillas.
MEF from uninfected control chinchillas with Eustachian tube
obstruction showed only scant numbers of inflammatory cells and no
detectable IL-1
or IL-8; hence, middle ear inflammation was most
likely a direct response to the pneumococcal middle ear inoculum.
| |
DISCUSSION |
|---|
|
|
|---|
Cytokines participate in middle ear inflammation as they do in many other infectious diseases. This study illustrates the close interrelationships among proinflammatory cytokines and between cytokines and acute inflammatory cells in MEF during the early phase of acute pneumococcal otitis media in the chinchilla model. This model is similar to human otitis media because the bacterial inoculum is very small. In the model, type 3 pneumococci grow in the middle ear much as they do in vitro with lag, log, and stationary phases (Fig. 1). Most pneumococcal serotypes are slowly eliminated by the chinchillas with low mortality even without antibiotic treatment (10).
IL-1
was detected in 50% of MEF samples at 1 h and peaked
6 h after pneumococcal inoculation, before appreciable
inflammatory cell accumulation, suggesting that IL-1
was produced by
cells in the middle ear mucosa. However, IL-1
and MEF neutrophil
concentrations were significantly correlated, suggesting that
neutrophils also produced IL-1
, perhaps contributing to the
secondary IL-1
increase after 24 h (Fig. 2).
IL-6 was detected in 50% of 2-h samples, then decreased between 4 and 24 h, and increased at 48 and 72 h, when the bacterial and inflammatory cell concentrations were stable, suggesting that IL-6 was produced by accumulated inflammatory cells. The early increase at 2 h could be attributed to production by cells in the middle ear mucosa.
IL-8 and TNF-
concentrations continued to increase at 72 h,
when the inflammatory cell concentration had stabilized, suggesting they were partially derived from inflammatory cells. The relative insensitivity of the IL-8 ELISA kit most likely contributed to detection of IL-8 in only about one-third of MEF samples. IL-8 alone
did not have significant correlation with lymphocytes, supporting the
theory that IL-8 is primarily a neutrophil chemoattractant. TNF-
may
also have been derived from middle ear mucosa, as was recently
demonstrated in endotoxin-induced otitis media in the chinchilla
model (7).
Serial fluid aspiration from a closed compartment may potentially alter
cellular and chemical composition of the compartment. However, the
middle ear space is dynamic, with cell and fluid distribution into and
out of the space across the middle ear membrane; thus, a small volume
of aspirate is likely to be reconstituted rather promptly. We had
sufficient data to examine the effect of initial versus subsequent
aspiration on samples obtained at 12 and 24 h. Cellular
concentration in MEF was lower in the subsequent aspirate but cytokine
(IL-1
) was higher in the subsequent aspirate, suggesting that
cytokines are replenished more rapidly than inflammatory cells can
migrate into the space. Human cytokine ELISA kits have been used by
others to study cytokine responses in experimental otitis media. In one
study, the presence of IL-1
in MEF after pneumococcal inoculation
was related to MEF presence before inoculation (14). We
previously reported that IL-1
and IL-6 concentrations in chinchilla
MEF increased with inflammatory cell influx accelerated by
penicillin treatment following pneumococcal inoculation
(28). However, the single MEF sampling time 24 h after
inoculation in the previous study might have missed the actual peaks of
IL-1
and IL-6. Moreover, the relatively low detection rate of
cytokines in our previous (28) and present experiment might
be due to low cross-reactivity between human anticytokine antibodies
and chinchilla cytokines. In a rat otitis media model,
lipopolysaccharide (LPS)-induced serum transudation into the middle ear
was attenuated by TNF binding protein, but not by IL-1 receptor
antagonist, suggesting that TNF, not IL-1, is a mediator of LPS-induced
otitis media (1). Although serum was not analyzed for
cytokines in this study, it seems unlikely that systemic cytokine
production occurred in the absence of bacteremia, a characteristic of
this serotype in chinchillas (28).
The contribution of cytokines to middle ear inflammation has been
studied in MEF obtained from children with chronic OME (5, 11, 16,
21, 22, 30, 32-34). IL-1
(33), TNF-
(33), and IL-6 (34) MEF concentrations were
inversely correlated with age, and IL-1
concentrations were higher
in purulent MEF than in serous or mucoid MEF (11, 16). IL-8
transcripts were detected in 75% of MEF from both pediatric and adult
chronic OME patients (30). Children with recurrent AOM had
significantly lower nasopharyngeal IL-1
, IL-6, and TNF-
production than healthy children (20). Higher levels of IL-8
and polymorphonuclear leukocyte products such as leukotriene B4 in MEF
were related to delayed recovery or AOM recurrence (5).
Higher TNF-
in MEF was associated with a history of multiple
tympanostomy tube placements, which indicates chronicity of the middle
ear disease (32). As in our experimental study, IL-1
,
IL-6, and TNF-
in MEF from children with OME were also highly
correlated each other (32). IL-8 concentration in MEF
obtained from children with OME was positively correlated with total
inflammatory cell numbers and percentage of neutrophils (22). Both IL-1
and TNF-
in MEF were correlated with
the concentration of IL-8 (21).
An important virulence factor in pneumococcal otitis media may be
pneumolysin since human monocytes exposed to pneumolysin in vitro
produced more IL-1
and TNF-
than unexposed control monocytes
(12). However, our study with a pneumolysin-deficient strain did not support a role for pneumolysin in otitis media pathogenesis (28).
Cytokines often act together. IL-1 from monocytes stimulated the
release of IL-6 and IL-8 (6). Conditions for IL-6 and IL-8
production are strikingly parallel (26, 31). TNF-
potentiated IL-8 secretion by histamine-stimulated endothelial cells
(13). IL-1
-stimulated peripheral blood mononuclear cells
induced IL-1
and TNF-
synthesis (8).
Recent studies have also shown that inflammatory cytokines can directly induce middle ear inflammation. Human recombinant IL-2 and TNF injected into the middle ear of guinea pigs caused an inflammatory middle ear effusion (4). Inoculation of human IL-8 into murine middle ears induced histological changes peaking 4 to 8 h after injection, and the changes were similar to those after injection of nonviable S. pneumoniae (15). Therefore, treatment strategies that reduce or neutralize inflammatory cytokines, such as administrating cytokine antibodies or cytokine receptors, may be effective adjuvants in otitis media management.
| |
ACKNOWLEDGMENT |
|---|
This study was supported by grant no. PO1-DC00133 from the National Institute on Deafness and Other Communication Disorders.
| |
FOOTNOTES |
|---|
* Corresponding author. Mailing address: Box 296 Mayo, 420 Delaware St. SE, Minneapolis, MN 55455. Phone: (612) 624-6159. Fax: (612) 624-8927. E-mail: giebi001{at}tc.umn.edu.
Current address: Department of Otolaryngology, Nigata University
School of Medicine, Nigata, Japan.
Editor: E. I. Tuomanen
| |
REFERENCES |
|---|
|
|
|---|
| 1. | Ball, S. S., J. Prazma, C. G. D. Dais, R. J. Triana, and H. C. Pillsbury. 1997. Role of tumor necrosis factor and interleukin-1 in endotoxin-induced middle ear effusions. Ann. Otol. Rhinol. Laryngol. 106:633-639[Medline]. |
| 2. | Bluestone, C. D., J. S. Stephenson, and L. M. Martin. 1992. Ten-year review of otitis media. Pediatr. Infect. Dis. J. 11:S7-S11[Medline]. |
| 3. | Canafax, D. M., N. Nonomura, G. R. Erdman, C. T. Le, S. K. Juhn, and G. S. Giebink. 1989. Experimental animal models for studying antimicrobial pharmacokinetics in otitis media. Pharm. Res. 6:279-285[Medline]. |
| 4. | Catanzaro, A., A. Ryan, S. Batcher, and S. I. Wasserman. 1991. The response to human rIL-1, rIL-2, and rTNF in the middle ear of guinea pigs. Laryngoscope 101:271-275[Medline]. |
| 5. | Chonmaitree, T., J. A. Patel, R. Garofalo, T. Uchida, T. Sim, M. J. Owen, and V. M. Howie. 1996. Role of leukotriene B4 and interleukin-8 in acute bacterial and viral otitis media. Ann. Otol. Rhinol. Laryngol. 105:968-974[Medline]. |
| 6. |
Colotta, F.,
F. Re,
M. Muzio,
R. Bertini,
N. Polentarutti,
M. Sironi,
J. G. Giri,
S. K. Dower,
J. E. Sims, and A. Mantovani.
1993.
Interleukin-1 type II receptor: a decoy target for IL-1 that is regulated by IL-4.
Science
261:472-475 |
| 7. | DeMaria, T. F., and D. M. Murwin. 1997. Tumor necrosis factor during experimental lipopolysaccharide-induced otitis media. Laryngoscope 107:369-372[Medline]. |
| 8. |
Endres, S.,
R. E. D. Ehitaker,
R. Ghorbani,
S. N. Meydani, and C. A. Dinarello.
1996.
Oral aspirin and ibuprofen increase cytokine-induced synthesis of IL- and of tumor necrosis factor- ex vivo.
Immunology
87:264-270[Medline].
|
| 9. | Giebink, G. S. 1989. The microbiology of otitis media. Pediatr. Infect. Dis. J. 8:S18-S20[Medline]. |
| 10. | Giebink, G. S., I. K. Berzins, and P. G. Quie. 1980. Animal models for studying pneumococcal otitis media and pneumococcal vaccine efficacy. Ann. Otol. Rhinol. Laryngol. 68(Suppl.):339-343. |
| 11. | Himi, T., T. Suzuki, H. Kodama, H. Takezawa, and A. Kataura. 1992. Immunologic characteristics of cytokines in otitis media with effusion. Ann. Otol. Rhinol. Laryngol. 101:21-25. |
| 12. |
Houldsworth, S.,
P. W. Andrew, and T. J. Mitchell.
1994.
Pneumolysin stimulates production of tumor necrosis factor alpha and interleukin-1 by human mononuclear phagocytes.
Infect. Immun.
62:1501-1503 |
| 13. |
Jeannin, P.,
Y. Delneste,
P. Gosset,
S. Molet,
P. Lassalle,
Q. Hamid,
A. Tsicopoulos, and A. B. Tonnel.
1994.
Histamine induces interleukin-8 secretion by endothelial cells.
Blood
84:2229-2233 |
| 14. | Johnson, M. D., J. E. Fitzgerald, G. Leonard, J. A. Burleson, and D. L. Kreutzer. 1994. Cytokines in experimental otitis media with effusion. Laryngoscope 104:191-196[Medline]. |
| 15. | Johnson, M., G. Leonard, and D. L. Kreutzer. 1997. Murine model of interleukin-8-induced otitis media. Laryngoscope 107:1405-1408[Medline]. |
| 16. | Juhn, S. K., W. J. Garvis, C. J. Lees, C. T. Le, and C. S. Kim. 1994. Determining otitis media severity from middle ear fluid analysis. Ann. Otol. Rhinol. Laryngol. 103:43-45. |
| 17. | Kawana, M. 1995. Early inflammatory changes of the Haemophilus influenzae-induced experimental otitis media. Auris Nasus Larynx 22:80-85[Medline]. |
| 18. |
Kawana, M.,
C. Kawana, and G. S. Giebink.
1992.
Penicillin treatment accelerates middle ear inflammation in experimental pneumococcal otitis media.
Infect. Immun.
60:1908-1912 |
| 19. |
Kawana, M.,
C. Kawana,
T. Yokoo,
P. G. Quie, and G. S. Giebink.
1991.
Oxidative metabolic products released from polymorphonuclear leukocytes in middle ear during experimental otitis media.
Infect. Immun.
59:4084-4088 |
| 20. |
Lindberg, K.,
B. Rynnel-Dagoo, and K.-G. Sundqvist.
1994.
Cytokines in nasopharyngeal secretions; evidence for defective IL-1 production in children with recurrent episodes of acute otitis media.
Clin. Exp. Immunol.
97:396-402[Medline].
|
| 21. | Maxwell, K. S., J. E. Fitzgerald, J. A. Burleson, G. Leonard, R. Carpenter, and D. L. Kreutzer. 1994. Interleukin-8 expression in otitis media. Laryngoscope 104:989-995[Medline]. |
| 22. | Nassif, P. S., S. Q. Simpson, A. A. Izzo, and P. J. Nicklais. 1997. Interleukin-8 concentration predicts the neutrophil count in middle ear effusion. Laryngoscope 107:1223-1227[Medline]. |
| 23. | Nonomura, N., G. S. Giebink, S. K. Juhn, T. Harada, and D. Aeppli. 1991. Pathophysiology of Streptococcus pneumoniae otitis media: kinetics of the middle ear biochemical and cytological host responses. Ann. Otol. Rhinol. Laryngol. 100:236-243[Medline]. |
| 24. | Nonomura, N., Y. Nakano, O. Fujioka, H. Niijima, M. Kawana, and M. Fujita. 1987. Experimentally induced otitis media with effusion following inoculation with the outer cell wall of nontypable Haemophilus influenzae. Arch. Oto-Rhino-Laryngol. 244:253-257[Medline]. |
| 25. | Nonomura, N., Y. Nakano, Y. Satoh, O. Fujioka, H. Niijima, and M. Fujita. 1986. Otitis media with effusion following inoculation of Haemophilus influenzae type b endotoxin. Arch. Oto-Rhino-Laryngol. 243:31-35[Medline]. |
| 26. | Rampart, M., A. G. Herman, B. Grillet, G. Opdenakker, and J. Van Damme. 1992. Development and application of a radioimmunoassay for interleukin-8: detection of interleukin-8 in synovial fluids from patients with inflammatory joint disease. Lab. Investig. 66:512-518[Medline]. |
| 27. | Sato, K. 1997. Experimental otitis media induced by nonviable Moraxella catarrhalis in the guinea pig model. Auris Nasus Larynx 24:233-238[Medline]. |
| 28. | Sato, K., M. K. Quartey, C. L. Liebeler, C. T. Le, and G. S. Giebink. 1996. Roles of autolysin and pneumolysin in middle ear inflammation caused by a type 3 Streptococcus pneumoniae in the chinchilla otitis media model. Infect. Immun. 64:1140-1145[Abstract]. |
| 29. | Sato, K., M. K. Quartey, C. L. Liebeler, and G. S. Giebink. 1995. Timing of penicillin treatment influences the course of Streptococcus pneumoniae-induced middle ear inflammation. Antimicrob. Agents Chemother. 39:1896-1898[Abstract]. |
| 30. | Takeuchi, K., K. Maesato, A. Yuta, and Y. Sakakura. 1994. Interleukin-8 gene expression in middle ear effusions. Ann. Otol. Rhinol. Laryngol. 103:404-407[Medline]. |
| 31. |
Van Snick, J.,
S. Cayphas,
A. Vink,
C. Uyttenhove,
P. G. Coulie,
M. R. Rubira, and J. Simpson.
1986.
Purification and NH2-terminal amino acid sequence of a T-cell-derived lymphokine with growth factor activity for B-cell hybridomas.
Proc. Natl. Acad. USA
83:9679-9683 |
| 32. | Yellon, R. F. 1995. Cytokines, immunoglobulins, and bacterial pathogens in middle ear effusions. Arch. Otolaryngol. Head Neck Surg. 121:865-869. |
| 33. | Yellon, R. F., G. Leonard, P. T. Marucha, R. Craven, R. J. Carpenter, W. B. Lehmann, J. A. Burleson, and D. L. Kreutzer. 1991. Characterization of cytokines present in middle ear effusions. Laryngoscope 101:165-169[Medline]. |
| 34. | Yellon, R. F., G. Leonard, P. Marucha, J. Sidman, R. Carpenter, J. Burleson, J. Carlson, and D. Kreutzer. 1992. Demonstration of interleukin 6 in middle ear effusions. Arch. Otolaryngol. Head Neck Surg. 118:745-748. |
This article has been cited by other articles:
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Copyright © 2009 by the American Society for Microbiology. For an alternate route to Journals.ASM.org, visit: http://intl-journals.asm.org | More Info»